VEGF-B Promotes Cancer Metastasis Through a VEGF-A–independent Mechanism and Serves As a Marker of Poor Prognosis for Cancer Patients

Xiaojuan Yang,Yin Zhang,Kayoko Hosaka,Patrik Andersson,Jian Wang,Fredrik Tholander,Ziquan Cao,Hiromasa Morikawa,Jesper Tegner,Yunlong Yang,Hideki Iwamoto,Sharon Lim,Yihai Cao

DOI: https://doi.org/10.1073/pnas.1503500112

2015-01-01

Abstract:The biological functions of VEGF-B in cancer progression remain poorly understood. Here, we report that VEGF-B promotes cancer metastasis through the remodeling of tumor microvasculature. Knockdown of VEGF-B in tumors resulted in increased perivascular cell coverage and impaired pulmonary metastasis of human melanomas. In contrast, the gain of VEGF-B function in tumors led to pseudonormalized tumor vasculatures that were highly leaky and poorly perfused. Tumors expressing high levels of VEGF-B were more metastatic, although primary tumor growth was largely impaired. Similarly, VEGF-B in a VEGF-A-null tumor resulted in attenuated primary tumor growth but substantial pulmonary metastases. VEGF-B also led to highly metastatic phenotypes in Vegfr1 tk(-/-) mice and mice treated with anti-VEGF-A. These data indicate that VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism. High expression levels of VEGF-B in two large-cohort studies of human patients with lung squamous cell carcinoma and melanoma correlated with poor survival. Taken together, our findings demonstrate that VEGF-B is a vascular remodeling factor promoting cancer metastasis and that targeting VEGF-B may be an important therapeutic approach for cancer metastasis.